Disclosure Of First-Time Adoption [Text Block]

GENFLOW BIOSCIENCES PLC - Filing #5893549

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
5,591,100 GBP
4,830,375 GBP
104,912 GBP
252,805 GBP
403,008 GBP
499,693 GBP
4,003,865 GBP
224,906 GBP
4,190,900 GBP
87,752 GBP
2,366,473 GBP
231,341 GBP
4,190,900 GBP
2,143,520 GBP
87,752 GBP
Comprehensive income
20,934 GBP
- GBP
- GBP
1,587,235 GBP
1,566,301 GBP
1,866,780 GBP
6,435 GBP
1,860,345 GBP
- GBP
- GBP
Profit (loss)
- GBP
- GBP
- GBP
1,587,235 GBP
1,587,235 GBP
1,860,345 GBP
- GBP
1,860,345 GBP
- GBP
- GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.